These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 401277)

  • 1. Immunosuppressive effect of burn patient serum on burn patient lymphocytes and normal lymphocytes: association with sepsis.
    Constantian MB; Cohen IK
    Surg Forum; 1978; 29():599-600. PubMed ID: 401277
    [No Abstract]   [Full Text] [Related]  

  • 2. In vitro effects of complement inactivation upon burn-associated cell-mediated immunosuppression.
    Ferrara JJ; Dyess DL; Luterman A; Peterson RD; Curreri PW
    Am Surg; 1990 Sep; 56(9):571-4. PubMed ID: 2393202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thermal injury-associated immunosuppression: occurrence and in vitro blocking effect of post recovery serum.
    Ninnemann JL; Fisher JC; Wachtel TL
    J Immunol; 1979 May; 122(5):1736-41. PubMed ID: 448107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Temporal correlation of impaired immune response after thermal injury with susceptibility to infection in a murine model.
    Moss NM; Gough DB; Jordan AL; Grbic JT; Wood JJ; Rodrick ML; Mannick JA
    Surgery; 1988 Nov; 104(5):882-7. PubMed ID: 3263707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune response in burn patients in relation to HIV infection and sepsis.
    Sjöberg T; Mzezewa S; Jönsson K; Salemark L
    Burns; 2004 Nov; 30(7):670-4. PubMed ID: 15475140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The clinical significance of changes in immunological function of T lymphocyte in severe burn patients with sepsis].
    Dong N; Yao YM; Cao YJ; He LX; Yu Y; Chai JK; Sheng ZY
    Zhonghua Shao Shang Za Zhi; 2007 Apr; 23(2):84-7. PubMed ID: 17649877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Local and systemic interactions related to serum transforming growth factor-beta levels in burn wounds of various depths.
    Sakallioğlu AE; Başaran O; Ozdemir BH; Arat Z; Yücel M; Haberal M
    Burns; 2006 Dec; 32(8):980-5. PubMed ID: 17045746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of sepsis with an immunosuppressive polypeptide in the serum of burn patients.
    Constantian MB
    Ann Surg; 1978 Aug; 188(2):209-15. PubMed ID: 686889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased burn-induced immunosuppression in lipopolysaccharide-resistant mice.
    Jobin N; Garrel DR; Bernier J
    Cell Immunol; 2000 Mar; 200(2):65-75. PubMed ID: 10753497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Postburn impaired cell-mediated immunity may not be due to lazy lymphocytes but to overwork.
    Deitch EA; Landry KN; McDonald JC
    Ann Surg; 1985 Jun; 201(6):793-802. PubMed ID: 3159354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Inhibitory effect of antimicrobial antibodies on the generalization of wound infection].
    Pal'tsyn AA; Chervonskaia NV; Grishina IA; Pobedina VG; Svetukhin AM; Badikova AK
    Biull Eksp Biol Med; 1993 Apr; 115(4):427-9. PubMed ID: 8049413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of numerical and phenotypic leukocyte changes during constant hydrocortisone infusion in normal humans with those in thermally injured patients.
    Calvano SE; Albert JD; Legaspi A; Organ BC; Tracey KJ; Lowry SF; Shires GT; Antonacci AC
    Surg Gynecol Obstet; 1987 Jun; 164(6):509-20. PubMed ID: 3589906
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunosuppression of the burned patient.
    Robins EV
    Crit Care Nurs Clin North Am; 1989 Dec; 1(4):767-74. PubMed ID: 2697225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of exchange therapy on postburn lymphocyte suppression.
    Warden GD; Ninnemann J; Stratta RJ; Saffle JR
    Surgery; 1984 Aug; 96(2):321-9. PubMed ID: 6235613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Burns and the immune network.
    Miller CL
    J Trauma; 1979 Nov; 19(11 Suppl):880-3. PubMed ID: 490713
    [No Abstract]   [Full Text] [Related]  

  • 16. The cellular basis of post-burn immunosuppression: macrophages and mediators.
    Schwacha MG; Chaudry IH
    Int J Mol Med; 2002 Sep; 10(3):239-43. PubMed ID: 12165794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An investigation of possible immunosuppression from ketamine and 100 percent oxygen in normal children.
    Wilson RD; Priano LL; Traber DL; Sakai H; Daniels JC; Ritzmann SE
    Anesth Analg; 1971; 50(3):464-70. PubMed ID: 5103786
    [No Abstract]   [Full Text] [Related]  

  • 18. Defective IL-2 production in patients with severe burns and sepsis.
    Rodrick ML; Wood JJ; Grbic JT; O'Mahony JB; Davis CF; Moss NM; Blazar BA; Demling RH; Mannick JA
    Lymphokine Res; 1986; 5 Suppl 1():S75-80. PubMed ID: 2878125
    [No Abstract]   [Full Text] [Related]  

  • 19. Spontaneous lymphocyte activity: an important but neglected component of the immunologic profile of the thermally injured patient.
    Deitch EA
    Surgery; 1985 Sep; 98(3):587-93. PubMed ID: 3875909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathogenic role of interleukin-6 in the development of sepsis. Part I: Study in a standardized contact burn murine model.
    Pallua N; von Heimburg D
    Crit Care Med; 2003 May; 31(5):1490-4. PubMed ID: 12771623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.